| bibliographicCitation |
Madsen-Duggan CB, Debenham JS, Walsh TF, Toupence RB, Huang SX, Wang J, Tong X, Lao J, Fong TM, Schaeffer M, Xiao JC, Huang CR-C, Shen C, Stribling DS, Shearman LP, Strack AM, MacIntyre DE, Van der Ploeg LHT, Goulet MT. Lead optimization of 5,6-diarylpyridines as CB1 receptor inverse agonists. Bioorganic & Medicinal Chemistry Letters. 2007 Apr;17(7):2031–5. doi: 10.1016/j.bmcl.2007.01.005. |